RubrYc Therapeutics, Inc. Email Format

BiotechnologyCalifornia, United States11-50 Employees

RubrYc Therapeutics, Inc. is a San Carlos, California-based biotechnology company focused on biotherapeutics discovery. Founded in 2017 and later spun out from HealthTell in 2018, it develops computational tools, chemical libraries, and analytics to analyze protein interactions. Its Interface Discovery Engine provides a framework to modulate therapeutically relevant protein interactions through molecular engineering. The company combines in silico simulations with empirical analyses of protein structures to address challenges in identifying and optimizing biotherapeutic candidates, including antibody discovery where epitope selection is critical.

It operates in the biotechnology research field, aiming to serve drug discovery efforts by uncovering on-target epitopes and novel targets. A development announced in 2020 reported discovery and pre-clinical data for RTX-003, a CD25-targeted monoclonal antibody aimed at depleting regulatory T cells in the tumor microenvironment.

Get verified RubrYc Therapeutics, Inc. emails free

Company overview Employee directory